RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Merck & Company Incorporated

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Top Merck & Company Incorporated Articles

Displaying items 12-22
  • Exploring therapeutic effects of MDMA on post-traumatic stress

    Exploring therapeutic effects of MDMA on post-traumatic stress
    It costs about $2,000 to buy an ounce of the illegal drug, the therapist said — enough for roughly 150 doses. She pays her longtime dealer in cash; he gives her a Ziploc bag of white powder. Back home, she scoops the contents into clear capsules....
  • Alexander Shulgin, chemist behind MDMA, dies at 88

     Alexander Shulgin, chemist behind MDMA, dies at 88
    Biochemist Alexander Shulgin accidentally discovered one of the most famous and infamous party drugs of the 1980s. He synthesized a compound called MDMA in 1976 in his backyard laboratory and, as was his tradition, tried it out on himself. "First...
  • Stock market up marginally after last week's rally

    Stock market up marginally after last week's rally
    The stock market nudged higher Monday after a handful of U.S. companies announced deals. Family Dollar's stock jumped following news that investor Carl Icahn has taken a stake in the company. The Standard & Poor's 500 index was up five points, or 0.3...
  • Fight over fighting's role in evolution enters round two

    Did evolution hand man a face that’s fit to take a punch? David R. Carrier, a University of Utah biologist who specializes in comparative biomechanics, believes that shortly after human-like primates stopped swinging from trees, they swung at each...
  • Bayer to buy Claritin, other brands from Merck for $14.2 billion

    Bayer to buy Claritin, other brands from Merck for $14.2 billion
    Bayer plans to buy Merck & Co.'s consumer health business for $14.2 billion, a deal that would expand the German drug maker's range of over-the-counter medications. The deal, announced Tuesday, would give Bayer control over popular household brands such...
  • Keep your swimmers safe at home

    Keep your swimmers safe at home
    Keep your swimmers safe at home By Amy Merck and Shari Berg, Tribune Content Agency Florida leads the country in drowning deaths of children ages 1-4 — three times the national average, according to the Safe & Healthy Children’s Coalition....
  • Blood tests could detect sexually-transmitted oral cancers

    Blood tests could detect sexually-transmitted oral cancers
    LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, according to a World Health Organisation-led team of...
  • VES Awards 2013 winners & nominees

    Visual Effects in a Visual Effects-Driven Feature Motion Picture "The Hobbit: An Unexpected Journey" | Joe Letteri, Eileen Moran, Eric Saindon, Kevin L. Sherwood "Prometheus" | Paul Butterworth, Charley Henley, Allen Maris, Richard Stammers "Life of...
  • Kenneth William Kengla, M.D.

    Kenneth William Kengla, M.D.
    Obituary for Kengla, Kenneth William, M.D.   Kenneth William Kengla, M.D. passed away on January 27, 2013.  He was 73 years old.   Dr. Kengla was an Orthopedic Surgeon for 35 years in Orange County.  He attended USC Medical School, was a member of...
  • TribU: Smart Negotiating -- get what you want

    TribU: Smart Negotiating -- get what you want
    At Northwestern University's Kellogg School of Management, course registration is a case in economics. Every student is allotted a bag of points and must spend them bidding against each other for seats in classes. The more popular the class, the more...
  • Big pharma: Few new antibiotics in the works

    Big pharma: Few new antibiotics in the works
    Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...